Recurrent pneumonia

Summary

Recurrent pneumonia (MONDO:0005936) is a disease. A subtype of pneumonia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	recurrent pneumonia
Mondo ID	MONDO:0005936
EFO	EFO:0007461
SNOMED CT	699014000
UMLS	C0694550
MedGen	195802
Is cancer (heuristic)	no

Also known as: recurrent pneumonia · recurrent pneumonia (disease)

Data availability: 1 HPO phenotype.

Disease family

This is a subtype of pneumonia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › respiratory tract infectious disorder › pneumonia › recurrent pneumonia

Related subtypes (10): pleuropneumonia, idiopathic interstitial pneumonia, bacterial pneumonia, bronchopneumonia, contagious pleuropneumonia, eosinophilic pneumonia, viral pneumonia, pneumocystosis, acute fibrinous and organizing pneumonia, bronchiolocentric pattern of interstitial pneumonia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.